ArticleFrontiers in pharmacology2026
Machine learning prediction of bile salt export pump inhibition with Boruta feature selection in imbalanced data.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Bile salt export pump (BSEP) inhibition is an important mechanistic risk factor for cholestatic drug-induced liver injury. Quantitative structure-activity relationship (QSAR) models may support early safety screening, but practical BSEP datasets are often limited in size and imbalanced. Methods: We evaluated a machine-learning workflow combining molecular descriptors and fingerprints, Boruta feature selection, and class-imbalance training. Multiple algorithms were assessed using cross-validation, a held-out test set, and an independent external validation set composed of compounds synthesized in an industrial research setting. Results: Tree-based models generally showed the strongest external performance. In particular, models using RDKit2D descriptors achieved Matthews correlation coefficients (MCC) above 0.65 and a ROC-AUC of 0.87, while several other tree-based model representation combinations achieved MCC values around 0.45-0.50. Boruta markedly reduced feature dimensionality, but its effect on predictive performance depended on both the molecular representation and learning algorithm; it was most beneficial for selected high-dimensional fingerprints and tree-based models, while offering limited or unfavorable effects in some support vector machine settings. Applicability-domain and SHAP analyses further revealed representation-dependent generalization patterns and highlighted contributions from lipophilicity, polarity, solubility, and molecular complexity. Discussion: Overall, the workflow maintained useful predictive performance under small and imbalanced conditions and provides a practical framework for early-stage BSEP risk screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.